Qingyi Zhu

Qingyi Zhu

Auto-generated profile, based on publicly available information

Qingyi Zhu

Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2022 in Atherosclerosis
Verified
Journal Article
Open access
QZQingyi Zhu
Qingyi Zhu
YXYichao Xiao
Yichao Xiao
MJMeng Jiang
Meng Jiang
XLXuanyou Liu
Xuanyou Liu
YCYuqi Cui
Yuqi Cui
ZLZhenguo Liu
Zhenguo Liu
Inflammation and reactive oxygen species (ROS) are important to the pathogenesis of atherosclerosis. The effect of antioxidants on atherosclerosis is inconsistent, and sometimes controversial. We aimed to test the hypothesis that attenuation of atherosclerosis by N-acetylcysteine (NAC) depends on NAC treatment timing and duration. Male LDL receptor deficient (LDLR-/-) mice were fed a normal diet (ND) and divided into controls (on ND for 24 months), models 1-2 (at age of 9 months, starting NAC treatment for 3 or 6 months), and model 3 (at age of 18 months, starting NAC treatment for 6 months). To determine if hyperlipidemia compromises NAC treatment outcome, mice were fed a high fat diet (HFD) starting at age of 6 weeks and treated with NAC starting at 9 months of age for 6 months. NAC treatment for 6 months, not for 3 months, significantly attenuated atherosclerosis progression, but did not reverse atherosclerotic lesions, in aging LDLR-/- mice on ND. NAC had no effect on atherosclerotic lesions in mice on HFD. NAC treatment significantly decreased aortic ROS production, and the levels of inflammatory cytokines in serum and aorta of aging LDLR-/- mice with increased CD146 level. Bone marrow transplantation study with GFP-positive bone marrow cells showed that NAC treatment preserved M2 population and M2 polarization in the aorta of LDLR-/- mice. Early and adequate NAC treatment could effectively attenuate inflammation and atherosclerosis progression with preserved M2 population and increased CD146 level in aging LDLR-/- mice without extreme hyperlipidemia.

28 November 2025 in Current Problems in Cardiology
Verified
Journal Article
Open access
XMXinyu Ma
Xinyu Ma
SZShenghua Zhou
Shenghua Zhou
QZQingyi Zhu
Qingyi Zhu
Vascular aging is a fundamental biological process underlying many age-related cardiovascular diseases. Although traditional risk factors have been widely studied, vascular dysfunction progresses with aging even in individuals without classic risk factors. Current studies often focus on individual organs or single-cell types and pathways, resulting in limited understanding of the multidimensional mechanisms of vascular aging. We systematically retrieved "vascular aging" transcriptomic datasets from the Gene Expression Omnibus (GEO) database. Five datasets meeting strict inclusion criteria for physiological vascular aging were selected. Differentially expressed genes (DEGs) between young and aged groups were identified using linear modeling and batch correction. Functional enrichment analyses, including GO, KEGG, and GSEA, were performed to elucidate biological processes and signaling pathways. Protein-protein interaction (PPI) networks were constructed, hub genes identified using CytoHubba, and regulatory networks (miRNA, lncRNA, transcription factors) were analyzed. Potential drug-gene interactions were evaluated through enrichment and molecular docking. A total of 21 aging-related DEGs were identified, mainly enriched in biological processes related to immune regulation and cell cycle activity. Four hub genes-PPARG, IRF7, VCAN, and SDC1-were identified as central regulators. GSEA revealed activation of interferon signaling, inflammatory response, p53, and KRAS pathways in aged vasculature, while young vasculature was enriched in E2F, MYC, and oxidative phosphorylation pathways. Drug enrichment analysis indicated that Heparan sulfate exhibited strong binding potential to VCAN and may represent a promising anti-aging candidate. This systems biology study reveals key molecular mechanisms and targets in natural vascular aging. VCAN and associated inflammatory and metabolic pathways may play pivotal roles in age-associated vascular dysfunction, providing a foundation for targeted anti-aging interventions and personalized medicine strategies.